Implications of the urokinase study concerning the surgical treatment of pulmonary embolism.
D001794:Blood Pressure; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011653:Pulmonary Diffusing Capacity; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D012008:Recurrence
D005343:Fibrinolytic Agents; D006493:Heparin